These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

638 related articles for article (PubMed ID: 23419361)

  • 1. Yes-associated protein up-regulates Jagged-1 and activates the Notch pathway in human hepatocellular carcinoma.
    Tschaharganeh DF; Chen X; Latzko P; Malz M; Gaida MM; Felix K; Ladu S; Singer S; Pinna F; Gretz N; Sticht C; Tomasi ML; Delogu S; Evert M; Fan B; Ribback S; Jiang L; Brozzetti S; Bergmann F; Dombrowski F; Schirmacher P; Calvisi DF; Breuhahn K
    Gastroenterology; 2013 Jun; 144(7):1530-1542.e12. PubMed ID: 23419361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of Chromosome Instability by Activation of Yes-Associated Protein and Forkhead Box M1 in Liver Cancer.
    Weiler SME; Pinna F; Wolf T; Lutz T; Geldiyev A; Sticht C; Knaub M; Thomann S; Bissinger M; Wan S; Rössler S; Becker D; Gretz N; Lang H; Bergmann F; Ustiyan V; Kalin TV; Singer S; Lee JS; Marquardt JU; Schirmacher P; Kalinichenko VV; Breuhahn K
    Gastroenterology; 2017 Jun; 152(8):2037-2051.e22. PubMed ID: 28249813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Yes-associated protein (YAP) induces a secretome phenotype and transcriptionally regulates plasminogen activator Inhibitor-1 (PAI-1) expression in hepatocarcinogenesis.
    Marquard S; Thomann S; Weiler SME; Bissinger M; Lutz T; Sticht C; Tóth M; de la Torre C; Gretz N; Straub BK; Marquardt J; Schirmacher P; Breuhahn K
    Cell Commun Signal; 2020 Oct; 18(1):166. PubMed ID: 33097058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [YAP induces chromosomal instability in liver cancer patients].
    Weiler S
    Pathologe; 2018 Dec; 39(Suppl 2):185-188. PubMed ID: 30206654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TEA Domain Transcription Factor 4 Is the Major Mediator of Yes-Associated Protein Oncogenic Activity in Mouse and Human Hepatoblastoma.
    Zhang J; Liu P; Tao J; Wang P; Zhang Y; Song X; Che L; Sumazin P; Ribback S; Kiss A; Schaff Z; Cigliano A; Dombrowski F; Cossu C; Pascale RM; Calvisi DF; Monga SP; Chen X
    Am J Pathol; 2019 May; 189(5):1077-1090. PubMed ID: 30794805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of Rac GTPase Activating Protein 1 Contributes to Proliferation of Cancer Cells by Reducing Hippo Signaling to Promote Cytokinesis.
    Yang XM; Cao XY; He P; Li J; Feng MX; Zhang YL; Zhang XL; Wang YH; Yang Q; Zhu L; Nie HZ; Jiang SH; Tian GA; Zhang XX; Liu Q; Ji J; Zhu X; Xia Q; Zhang ZG
    Gastroenterology; 2018 Oct; 155(4):1233-1249.e22. PubMed ID: 30009820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-199a-3p inhibits cell proliferation and induces apoptosis by targeting YAP1, suppressing Jagged1-Notch signaling in human hepatocellular carcinoma.
    Ren K; Li T; Zhang W; Ren J; Li Z; Wu G
    J Biomed Sci; 2016 Nov; 23(1):79. PubMed ID: 27832779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RASSF1A-mediated regulation of AREG via the Hippo pathway in hepatocellular carcinoma.
    Ahn EY; Kim JS; Kim GJ; Park YN
    Mol Cancer Res; 2013 Jul; 11(7):748-58. PubMed ID: 23594797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional Enhancer Factor Domain Family member 4 Exerts an Oncogenic Role in Hepatocellular Carcinoma by Hippo-Independent Regulation of Heat Shock Protein 70 Family Members.
    Coto-Llerena M; Tosti N; Taha-Mehlitz S; Kancherla V; Paradiso V; Gallon J; Bianco G; Garofoli A; Ghosh S; Tang F; Ercan C; Christofori GM; Matter MS; Droeser RA; Zavolan M; Soysal SD; von Flüe M; Kollmar O; Terracciano LM; Ng CKY; Piscuoglio S
    Hepatol Commun; 2021 Apr; 5(4):661-674. PubMed ID: 33860124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Notch signalling beyond liver development: emerging concepts in liver repair and oncogenesis.
    Morell CM; Fiorotto R; Fabris L; Strazzabosco M
    Clin Res Hepatol Gastroenterol; 2013 Nov; 37(5):447-54. PubMed ID: 23806629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silybin-mediated inhibition of Notch signaling exerts antitumor activity in human hepatocellular carcinoma cells.
    Zhang S; Yang Y; Liang Z; Duan W; Yang J; Yan J; Wang N; Feng W; Ding M; Nie Y; Jin Z
    PLoS One; 2013; 8(12):e83699. PubMed ID: 24386256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Yes-associated protein/TEA domain family member and hepatocyte nuclear factor 4-alpha (HNF4α) repress reciprocally to regulate hepatocarcinogenesis in rats and mice.
    Cai WY; Lin LY; Hao H; Zhang SM; Ma F; Hong XX; Zhang H; Liu QF; Ye GD; Sun GB; Liu YJ; Li SN; Xie YY; Cai JC; Li BA
    Hepatology; 2017 Apr; 65(4):1206-1221. PubMed ID: 27809333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S1P Stimulates Proliferation by Upregulating CTGF Expression through S1PR2-Mediated YAP Activation.
    Cheng JC; Wang EY; Yi Y; Thakur A; Tsai SH; Hoodless PA
    Mol Cancer Res; 2018 Oct; 16(10):1543-1555. PubMed ID: 29903770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The miR-143/145 cluster is a novel transcriptional target of Jagged-1/Notch signaling in vascular smooth muscle cells.
    Boucher JM; Peterson SM; Urs S; Zhang C; Liaw L
    J Biol Chem; 2011 Aug; 286(32):28312-21. PubMed ID: 21685392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hippo signaling interactions with Wnt/β-catenin and Notch signaling repress liver tumorigenesis.
    Kim W; Khan SK; Gvozdenovic-Jeremic J; Kim Y; Dahlman J; Kim H; Park O; Ishitani T; Jho EH; Gao B; Yang Y
    J Clin Invest; 2017 Jan; 127(1):137-152. PubMed ID: 27869648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High mobility group protein B1 controls liver cancer initiation through yes-associated protein -dependent aerobic glycolysis.
    Chen R; Zhu S; Fan XG; Wang H; Lotze MT; Zeh HJ; Billiar TR; Kang R; Tang D
    Hepatology; 2018 May; 67(5):1823-1841. PubMed ID: 29149457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrin α2β1 inhibits MST1 kinase phosphorylation and activates Yes-associated protein oncogenic signaling in hepatocellular carcinoma.
    Wong KF; Liu AM; Hong W; Xu Z; Luk JM
    Oncotarget; 2016 Nov; 7(47):77683-77695. PubMed ID: 27765911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-activation of PIK3CA and Yap promotes development of hepatocellular and cholangiocellular tumors in mouse and human liver.
    Li X; Tao J; Cigliano A; Sini M; Calderaro J; Azoulay D; Wang C; Liu Y; Jiang L; Evert K; Demartis MI; Ribback S; Utpatel K; Dombrowski F; Evert M; Calvisi DF; Chen X
    Oncotarget; 2015 Apr; 6(12):10102-15. PubMed ID: 25826091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Yes-associated protein (YAP) binds to HIF-1α and sustains HIF-1α protein stability to promote hepatocellular carcinoma cell glycolysis under hypoxic stress.
    Zhang X; Li Y; Ma Y; Yang L; Wang T; Meng X; Zong Z; Sun X; Hua X; Li H
    J Exp Clin Cancer Res; 2018 Sep; 37(1):216. PubMed ID: 30180863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GSI-I has a better effect in inhibiting hepatocellular carcinoma cell growth than GSI-IX, GSI-X, or GSI-XXI.
    Shen Y; Lv D; Wang J; Yin Y; Miao F; Dou F; Zhang J
    Anticancer Drugs; 2012 Aug; 23(7):683-90. PubMed ID: 22569108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.